The AZEK Company Inc. (NYSE:AZEK – Get Free Report) has earned an average rating of “Moderate Buy” from the seventeen ratings firms that are covering the company, MarketBeat Ratings reports. Four analysts have rated the stock with a hold rating and thirteen have issued a buy rating on the company. The average 1 year price target among brokerages that have covered the stock in the last year is $45.33.
AZEK has been the subject of several research analyst reports. Barclays boosted their target price on shares of AZEK from $50.00 to $58.00 and gave the stock an “overweight” rating in a research report on Thursday, April 4th. Benchmark began coverage on shares of AZEK in a research report on Friday, April 19th. They set a “buy” rating and a $55.00 price objective for the company. Robert W. Baird lowered their price objective on shares of AZEK from $60.00 to $58.00 and set an “outperform” rating for the company in a research report on Thursday, May 9th. Truist Financial reaffirmed a “buy” rating and set a $57.00 price objective on shares of AZEK in a research report on Tuesday, June 18th. Finally, Citigroup boosted their price objective on shares of AZEK from $46.00 to $50.00 and gave the company a “neutral” rating in a research report on Friday, April 5th.
Get Our Latest Research Report on AZEK
Insider Transactions at AZEK
Institutional Trading of AZEK
Institutional investors and hedge funds have recently added to or reduced their stakes in the business. UBS Group AG raised its holdings in shares of AZEK by 245.4% during the third quarter. UBS Group AG now owns 70,594 shares of the company’s stock valued at $2,099,000 after acquiring an additional 50,158 shares during the period. Rhumbline Advisers raised its holdings in shares of AZEK by 6.8% during the third quarter. Rhumbline Advisers now owns 146,293 shares of the company’s stock valued at $4,351,000 after acquiring an additional 9,335 shares during the period. PNC Financial Services Group Inc. raised its holdings in shares of AZEK by 85.8% during the third quarter. PNC Financial Services Group Inc. now owns 23,024 shares of the company’s stock valued at $685,000 after acquiring an additional 10,635 shares during the period. Envestnet Asset Management Inc. raised its holdings in shares of AZEK by 33.8% during the third quarter. Envestnet Asset Management Inc. now owns 201,825 shares of the company’s stock valued at $6,002,000 after acquiring an additional 50,955 shares during the period. Finally, FMR LLC raised its holdings in shares of AZEK by 54.2% during the third quarter. FMR LLC now owns 2,348,478 shares of the company’s stock valued at $69,844,000 after acquiring an additional 825,683 shares during the period. 97.44% of the stock is owned by institutional investors and hedge funds.
AZEK Price Performance
AZEK opened at $41.63 on Wednesday. The company has a 50-day moving average of $45.69 and a 200-day moving average of $44.40. The company has a market capitalization of $6.06 billion, a P/E ratio of 40.81, a PEG ratio of 1.33 and a beta of 1.88. AZEK has a 1-year low of $25.03 and a 1-year high of $50.78. The company has a debt-to-equity ratio of 0.42, a quick ratio of 2.21 and a current ratio of 3.40.
AZEK Company Profile
The AZEK Company Inc engages in the design, manufacturing, and selling of building products for residential, commercial, and industrial markets in the United States and Canada. It operates through two segments: Residential and Commercial. The Residential segment designs and manufactures engineered outdoor living products, such as decking, railing, trim and molding, siding and cladding, pergolas and cabanas, and accessories under the TimberTech, AZEK Exteriors, VERSATEX, ULTRALOX, StruXure, and INTEX brands.
See Also
- Five stocks we like better than AZEK
- How to Find Undervalued Stocks
- RXO Shares Surge Following New Acquisition Deal
- What is a Dividend Harvesting Strategy and How Can Investors Profit from it?
- 3 Stock Dips Insiders Are Buying: Vestis, Shenandoah, Treace
- CD Calculator: Certificate of Deposit Calculator
- Biotech Stock Breakout: IBB Eyes Resistance with Amgen and Vertex
Receive News & Ratings for AZEK Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AZEK and related companies with MarketBeat.com's FREE daily email newsletter.